Akorn FDA Report Added To Fresenius Trial Record
A Delaware vice chancellor ruled Tuesday that an inspection report by federal regulators be included in the trial record in the battle over Fresenius Kabi AG's bid to walk away from...To view the full article, register now.
Already a subscriber? Click here to view full article